Financial Markets
Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
Shilpa Medicare (SML) surged 16.25% to Rs 657.30 after the company's CDMO customer, Unicycive Therapeutics, Inc. has reported positive results from pivotal clinical trial of Oxylanthanum Carbonate (OLC) to treat kidney diseases.
![Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC](https://img.easybranches.com/uploads/news/2024/07/shilpa-medicare-sizzles-after-unicycive-gets-positive-results-in-clinical-trials-of-olc.jpg)
Related
Share this page
Guest Posts by Easy BranchesGet Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.